MSCI ACWI IMI Immuno-Oncology Index

The MSCI ACWI IMI Immuno-oncology Index aims to represent the performance of a set of companies that are associated with research, development, and commercialization of products for cancer immunotherapy, also known as Immuno-oncology. Immuno-oncology is a form of cancer treatment that uses the power of the body’s own immune system to prevent, control and eliminate cancer.
Index code
752570
Index type
Equity
Benchmark administrator
--
Div Yld (%)
2.41
P/E
32.82
P/E Fwd
23.74
P/BV
3.83
Number of constituents
48
Index Market Cap
$2.20 T
Largest constituent Market Cap
$118.36 B
Smallest constituent Market Cap
$1.56 B
Average constituent Market Cap
$45.91 B
Median constituent Market Cap
$21.64 B
Does this benchmark pursue ESG objectives?
No
Data as of June 30, 2025 

Want to learn more about MSCI indexes?
Get in touch.